Czechia – Immunosuppressive agents – Selektivní Imunosupresiva - Vedolizumab_VII.
Institut klinické a experimentální medicíny awarded Kč101M to Takeda Pharmaceuticals Czech Republic s.r.o. for Professional Services & Consulting in April 2026 — one of 690 awards this buyer has made, above its typical award size.
Buying agency
Institut klinické a experimentální medicínyWinning supplier
Takeda Pharmaceuticals Czech Republic s.r.o.Contract description
Czechia – Immunosuppressive agents – Selektivní Imunosupresiva - Vedolizumab_VII.
Related awards · Institut klinické a experimentální medicíny
690 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-274488-2025IMOS Brno, a.s.Kč375M29 Apr 2025 Construction
- ocds-ted-440632-2026Avenier a.s.Kč289M26 Jun 2026 Healthcare
- ocds-ted-746939-2024PROMEDICA PRAHA GROUP, a.s.Kč164M06 Dec 2024 Professional Services
Other wins · Takeda Pharmaceuticals Czech Republic s.r.o.
131 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-319082-2025Fakultní nemocnice u sv. Anny v BrněKč222M19 May 2025 Healthcare
- ocds-ted-382470-2026-2Fakultní nemocnice Hradec KrálovéKč220M04 Jun 2026 Professional Services
- ocds-ted-399276-2026-3Fakultní nemocnice Hradec KrálovéKč220M11 Jun 2026 Professional Services
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Institut klinické a experimentální medicíny and Takeda Pharmaceuticals Czech Republic s.r.o. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back